We are live on ! Find out more

2,221 hedge funds and large institutions have $101B invested in Amgen in 2020 Q4 according to their latest regulatory filings, with 259 funds opening new positions, 919 increasing their positions, 762 reducing their positions, and 131 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 259 | Existing positions closed: 131

21% more repeat investments, than reductions

Existing positions increased: 919 | Existing positions reduced: 762

4% more funds holding

Funds holding: 2,1282,221 (+93)

0.68% less ownership

Funds ownership: 76.13%75.45% (-0.68%)

11% less capital invested

Capital invested by funds: $113B → $101B (-$12.2B)

14% less call options, than puts

Call options by funds: $933M | Put options by funds: $1.09B

53% less funds holding in top 10

Funds holding in top 10: 11152 (-59)

Holders
2,221
Holders Change
+93
Holders Change %
+4.37%
% of All Funds
39.12%
Holding in Top 10
52
Holding in Top 10 Change
-59
Holding in Top 10 Change %
-53.15%
% of All Funds
0.92%
New
259
Increased
919
Reduced
762
Closed
131
Calls
$933M
Puts
$1.09B
Net Calls
-$155M
Net Calls Change
-$290M

AMGN Hedge Fund Activity: Q4 2020 in Review

2,221 of the 5,677 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2020, worth a combined $101B — down 11% from $113B a quarter earlier.

Buyers outnumbered sellers: 259 funds opened new AMGN positions and 131 closed out — a net gain of 128 holders — while 919 added to existing stakes and 762 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $272M. The largest seller was JP Morgan Chase, cutting an estimated $699M.

  • 2,221 institutional investors held Amgen (AMGN) as of Q4 2020, up from 2,128 in Q3 2020.
  • Funds reported $101B of Amgen stock for Q4 2020, down 11% quarter-over-quarter.
  • 259 funds opened new Amgen positions in Q4 2020 and 131 closed out, a net change of +128 holders.
  • The largest Amgen buyer in Q4 2020 was Morgan Stanley, an estimated $272M added.
  • The largest Amgen seller in Q4 2020 was JP Morgan Chase, an estimated $699M sold.

Based on aggregated 13F filings for Q4 2020.